新功能、新界面、新体验,扫描即可下载生物谷APP!
首页 » BIOON报道 » 合约研究机构TranScrip进军香港

合约研究机构TranScrip进军香港

来源:生物谷 2013-10-10 22:19

2013年10月10日讯 /生物谷BIOON/ --英国著名合约研究机构TranScrip公司宣布在香港开设办事处,这表明TransScrip公司将以香港为跳板进军亚洲市场。公司表示在香港的业务拓展是公司在亚太地区发展战略的下一步。此前,公司于去年底在澳大利亚开设了分公司。

TranScrip公司是一家提供点对点客户解决方案和提供药物研发服务一集其他常规生物技术服务的合约研究机构。公司目前已经在4个国家与超过80家企业建立了合作关系。(生物谷Bioon.com)

详细英文报道:

Fresh off making its U.S. landfall, British CRO TranScrip Partners has expanded into Hong Kong, bringing its development and marketing services to Asia.

With the launch of its Hong Kong office, TranScrip has an up-front seat for the burgeoning drug development scene in the Asia-Pacific region, the company said.

"Establishing TranScrip's office in Hong Kong is the next step in our global strategy for growth and will consolidate our presence in Asia-Pacific, a region which we see as being highly significant with regard to pharmaceutical drug development and sales," Managing Partner Flic Gabbay said in a statement.

The ribbon-cutting follows TranScrip's April expansion into the U.S., when the CRO set up shop in Philadelphia. TranScrip launched an operation in Australia late last year.

The CRO bills itself as an end-to-end solutions for clients, handling drug development, medical affairs, pharmacovigilance, regulatory services and medical writing for pre- and post-approval. The company has thus far partnered with more than 80 companies across four continents.

 

温馨提示:87%用户都在生物谷APP上阅读,扫描立刻下载! 天天精彩!


相关标签

最新会议 培训班 期刊库